跳至主要内容
临床试验/NCT05422677
NCT05422677已完成不适用

An Observational Study to Evaluate the Effectiveness and Safety of the Treatment of Tamsulosin in Korean Adult Males Diagnosed With Benign Prostatic Hyperplasia

Hanmi Pharmaceutical Company Limited1 个研究点 分布在 1 个国家目标入组 4,698 人开始时间: 2019年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,698
试验地点
1
主要终点
LUTS (Lower Tract Symptoms) improvement effect evaluated in patients with BPH symptoms after Tamsulosin treatment

研究概览

简要总结

In this study, BPH patients visited the institutions during the study period and the effectiveness and safety of the treatment of Tamsulosin(Hanmi Tams® Capsule) in real-practice.

During the routine medical visit, according to the investigator's judgment, with diagnosis that the Tamsulosin prescription is appropriate, and after deciding to start treatment, patients with BPH who agreed to participate in the study were administered Tamsulosin.

As this study is a non-interventional observational study, all subjects received prescriptions according to the routine treatment procedure, and there were no visits or procedures required according to the observational study protocol.

详细描述

This study is a multicenter, prospective, non-interventional, observational study of men administering Tamsulosin(Hanmi Tams® Capsule) to treat BPH.

Data will be collected from patients receiving routine treatment at hospitals in South Korea. Each subject visit the institution according to the protocol that designed the follow-up visits for six months to examine the effectiveness and safety of Tamsulosin.

This study will approved by the institutions' IRBs and is in compliance with clinical research ethics regulations.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male was diagnosed with Benign Prostatic Hyperplasia
  • Those who first started taking Hanmi Tams®
  • Those who voluntarily consented in writing to this study

排除标准

  • Patients for whom use of Hanmi Tams® is prohibited

研究组 & 干预措施

single arm, single group(No interventional)

Observational

干预措施: Hanmi Tams® Capsule (Drug)

结局指标

主要结局

LUTS (Lower Tract Symptoms) improvement effect evaluated in patients with BPH symptoms after Tamsulosin treatment

时间窗: 6 months

To measure the level of LUTS (Lower Tract Symptoms), the IPSS was calculated. : The International Prostate Symptom Score (IPSS) is used to assess the severity of LUTS (Lower Tract Symptoms) and to monitor disease progression. The IPSS is calculated from 7 questions regarding incomplete emptying, frequency, intermittency, urgency, weak stream, and straining \[rated as 0 (not at all) to 5 (almost always)\], as well as how many times on average a participant has to get up to urinate at night (0=none to 5=5 times or more). The total score is classified as follows: 0 to 7 = mildly symptomatic; 8 to 19 = moderately symptomatic; and 20 to 35 = severely symptomatic.

次要结局

未报告次要终点

研究者

发起方
Hanmi Pharmaceutical Company Limited
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

An Observational Study of Tamsulosin in Patients... | 临床试验